Third Quarter 2025 Earnings Presentation November 4, 2025 Forward-Looking Statements Certain statements set forth in this presentation constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar express ...

Assets Under Management (AUM) - AUM increased by $9.1 billion during Q3, reaching $49.1 billion[9] - AUM surpassed $50 billion for the first time in October[9] - Physical Trusts AUM increased by $6.5 billion or 21% during the quarter[25] - Year-to-date, Physical Trusts have gained $15.4 billion or 64% in AUM[25] - ETF AUM is up sharply in 2025, increasing by 83%[31] Financial Performance - The company bought back 15,386 shares during the quarter at an average price of $64.99/share, totaling $1 million[21] - Year-to-date, the company bought back 28,601 shares at an average price of $54.27/share, totaling $1.6 million[21] - Third quarter dividend increased by 33% to $0.40 per share from the second quarter's $0.30 per share[9, 22] - Adjusted EBITDA reached $31.9 million for Q3 2025, with an adjusted EBITDA margin of 65%[43] - Net income for the period was $13.2 million, resulting in a net income margin of 20%[43]

INVESTOR PRESENTATION INSTALLED BUILDING PRODUCTS Q3 2025 NYSE: IBP NOV 5, 2025 Safe Harbor This presentation contains "forward-looking statements" as defined under U.S. federal securities laws. Forward -looking statements are generally identified by the use of the words "will," "may," "believes," "expects," "forecast," "intends," "anticipates," "projects," "outlook," "target," "plans" and "seeks," and, in each case their negative, and other variations or comparable terminology. Forward-looking statements a ...

Financial Performance - Q3 2025 - Total revenues increased to $386 million from $376 million in Q2 2025[17], a rise of $9.9 million[18] - Adjusted EBITDA increased to $67 million from $61 million in Q2 2025[17], an increase of $6.4 million[18] - The company made $24.8 million in accelerated principal payments on the UKSAR Debt facility[16] Segment Performance - Offshore Energy Services revenues decreased by $2.4 million, from $253 million to $250 million[20, 21] - Government Services revenues increased by $8.4 million, from $93 million to $101 million[25, 27] - Other Services revenues increased by $3.8 million, from $31 million to $35 million[33, 36] Outlook for 2025 and 2026 - Total revenue is projected to be between $1455 million and $1525 million for 2025, and between $1580 million and $1690 million for 2026[38] - Adjusted EBITDA is projected to be between $240 million and $250 million for 2025, and between $295 million and $325 million for 2026[38] Balance Sheet and Capital Allocation - The company has $245.5 million of unrestricted cash and total liquidity of $313.4 million[41] - Net Debt is $441 million as of September 30, 2025[42] - The company plans to initiate a quarterly dividend program in Q1 2026, with an initial dividend of $0.125 per share ($0.50 annualized)[49]

Acquisition of NuVista Energy - Ovintiv's acquisition of NuVista Energy is expected to generate approximately 10% Free Cash Flow per share accretion[9, 24] - The acquisition enhances Montney scale with approximately 25 Mbbls/d of oil production and approximately 930 net 10k locations for approximately $13 million per location[9] - Ovintiv anticipates approximately $100 million in expected durable annual synergies from the NuVista acquisition[24, 41] - The acquisition is valued at approximately $27 billion enterprise value[28, 78] Q3 2025 Results and Updated Guidance - Ovintiv's 3Q25 oil and condensate production reached 212 Mbbls/d, surpassing the guidance of 202-208 Mbbls/d[11] - 3Q25 Free Cash Flow was $351 million and Net Debt reduction in 3Q25 was $126 million[13] - The company updated its FY25E oil and condensate production guidance to 208-210 Mbbls/d[18] - Ovintiv anticipates approximately a 50% decrease in 2025 cash taxes, representing approximately $75 million, due to internal restructuring[20] Permian Basin Expansion - Ovintiv added approximately 170 net 10k locations in the Permian YTD October 2025 for approximately $15 million per location[9, 62]

Financial Performance - Net sales increased by 6.6% year-over-year, while organic net sales decreased by 9.1% to $123.1 million[6] - Adjusted EBITDA decreased year-over-year to $14.1 million, resulting in an adjusted EBITDA margin of 9.8%[6] - Free Cash Flow decreased year-over-year to ($1.1) million[6] - Adjusted Diluted EPS was $0.10[6] Strategic Initiatives and Outlook - The company maintained its 2025 financial guidance[8] - Accu-Fab integration is proceeding as planned, with expected completion by year-end 2025[8] - Increased 2026 Accu-Fab revenue synergies are projected to be $20 to $30 million, as the Data Center & Critical Power pipeline exceeds $100 million[8] End-Market Outlook - Commercial Vehicle market sales are expected to decline by 16%-26% in 2025[13] - Data Center & Critical Power is expected to grow by 12%-14% in 2025[18] - Accu-Fab acquisition is expected to add $32 - $36 million in net sales to the Data Center & Critical Power end market in 2H25[22] Capital Allocation - Net leverage ratio was 3.5x as of September 30, 2025, with a target of 3.0x or lower by the end of 2026[6, 32] - The company is prioritizing $7 – $10 million of investment in equipment and automation to meet high-growth Data Center & Critical Power demand over the next 18 months[28]

Financial Performance - The company's total revenue for Q3 2025 was $850 million, compared to $720.1 million in Q3 2024, representing an increase of approximately $130 million[29] - Base revenue for Q3 2025 was $848.6 million, compared to $678.7 million in Q3 2024, an increase of $169.9 million[29] - Net income attributable to common stock was $2.1 million in Q3 2025, compared to a loss of $3.7 million in Q3 2024, an increase of $5.8 million[29] - Adjusted EBITDA for Q3 2025 was $75.2 million, compared to $78.8 million in Q3 2024, a decrease of $3.5 million[29] Bookings and Backlog - Total bookings for Q3 2025 were approximately $815 million[5] - The company's backlog at the end of the quarter was $5.9 billion[18] - Year-to-date book to bill ratio is 1.8x[18] Outlook - The company raised its full year 2025 revenue guidance to $2.80 - $2.90 billion[42] - The company expects year-end 2025 leverage ratio to be 3.3x to 3.4x[48] Strategic Initiatives - The company is targeting a 50/50 lease vs buy strategy for equipment and machinery[51] - The company anticipates $50 million of operating leases in 2025[51]

Q4 FY25 Performance - Sales decreased by 8% to $478 million compared to Q4 FY24, but decreased by only 1% compared to the portfolio reset baseline of $484 million[15, 24] - Adjusted EBITDA increased by 110 bps to 249%, but decreased by 4% to $119 million compared to Q4 FY24[15] - Adjusted EPS decreased by 14% to $108[15] Business Unit Performance - Life Sciences sales decreased by 10% to $173 million, but decreased by only 2% compared to the reset results of $177 million; EBITDA margin increased by 260 bps to 318%[25] - Personal Care sales decreased by 7% to $151 million, but increased by 5% compared to the reset results of $143 million; EBITDA margin decreased by 50 bps to 285%[31] - Specialty Additives sales decreased by 9% to $131 million, but decreased by 6% compared to the reset results of $140 million; EBITDA margin increased by 200 bps to 221%[34] - Intermediates sales decreased by 8% to $33 million; EBITDA margin decreased by 1260 bps to 152%[28] Strategic Initiatives & Outlook - The company expects full-year fiscal 2026 sales to be between $1835 million and $1905 million, and adjusted EBITDA to be between $400 million and $430 million[46] - The company is targeting approximately $30 million in savings from restructuring and manufacturing optimization[47] - The company aims to achieve approximately $15 million in sales growth through innovation and approximately $20 million in sales growth through globalization initiatives[47] Financial Position - The company has approximately $08 billion in cash and revolver availability[72] - The company's net debt is $1169 million, with a net leverage of 29x[72]

Financial Performance - Third quarter net income reached $39 million, or $1.49 per share, nearly doubling from the previous year[8] - The combined ratio for the third quarter was 91.9%, and the year-to-date ROE was 12.7%, marking the best results in nearly 20 years[8] - Net investment income increased by 6% due to a 17% growth in fixed maturity income[8] - Adjusted operating income reached $40 million, compared to $21 million in the prior year[5] - Net premiums written grew by 7% to a third quarter record of $328 million[8, 15] Underwriting Performance - The net loss ratio improved by 5 percentage points to 57.3% in the third quarter[5] - The underwriting expense ratio improved to 34.6%, reflecting disciplined expense management and business growth[5, 15] - The catastrophe loss ratio was 1.3% in Q3, outperforming historical averages[5, 15] Production Results - Core commercial net written premium increased 22% from the prior year[17] - Core commercial rate increases moderated to 5.8% while maintaining strong margins[17] Investment Portfolio - Invested assets totaled $2.3 billion, with 89% allocated to fixed income securities[20] - The average credit rating on fixed maturity assets improved to AA[20] - Fixed maturity income increased 17% due to portfolio management and reinvestment at higher yields[21, 24]

Global Expansion & Unit Economics - International adjusted EBITDA is projected to grow 4x from 2022 to 2025F, driven by direct franchising and stronger unit economics[2] - The percentage of rooms under direct franchising is expected to increase from 19% in 2022 to 41% in 2025F[3] - EBITDA per unit is projected to increase from $9,000 in 2022 to $28,000 in 2025F[3] - Adjusted EBITDA is expected to increase from $10 million in 2022 to $39 million in 2025F, a 3x increase[3] Pipeline Composition & Growth Drivers - A new MFA partnership in China is expected to add 9,500 rooms[4] - 98% of the global pipeline is comprised of higher-revenue hotels with higher room count, RevPAR, and royalty rates[5] - Midscale and Extended Stay segments constitute 34% and 39% respectively of the 3Q 2025 Global Portfolio[6] - Conversions make up 35% of the 3Q 2025 Global Pipeline, while new builds account for 65%[6] - Average rooms per unit in the global pipeline are 96, compared to 86 in the global portfolio[6] - Average RevPAR in the global pipeline is $70, compared to $54 in the global portfolio[6] - Conversions are typically opened within 3-6 months, approximately 80% faster than new construction[6]